Pharma Stocks Are Down But There Is Still Value To Be Unlocked

+29.53%
Upside
32.64
Market
42.28
Trefis
RHHBY: Roche logo
RHHBY
Roche

Pharma Stocks Are Down But There Is Still Value To Be Unlocked. Consider the following:

  • Big pharma stocks were down 4%-9% in the first 7 trading days of 2016
  • Temporary dip due to S&P 500 falling by ~7% due to China’s economical woes
  • Nevertheless, Trefis coverage universe shows upside potential of 3% -27% for big pharma stocks

Roche_Q13

See our complete analysis for Merck, Pfizer, Johnson & Johnson, Roche and Bristol-Myers Squibb for better understanding of Trefis price estimate for these firms.

Relevant Articles
  1. Is Roche Stock Undervalued At $33?
  2. What’s Driving Roche Stock?
  3. Company Of The Day: Roche Holdings
  4. What’s Happening With Roche (RHHBY) Stock?
  5. What’s Next For Roche Stock?
  6. Should You Buy, Sell, Or Hold Roche Stock At $42?

Have questions about Roche? See the links below.

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com

See More at Trefis | View Interactive Institutional Research (Powered by Trefis)

Get Trefis Technology